InsidersTradesSigma
Follow the Bespoke Extracts, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Bespoke Extracts, Inc. has logged 31 reports. Market capitalisation: €1.1m. The latest transaction was disclosed on 8 January 2026 (Attribution). Among the most active insiders: FEINSOD MICHAEL. All data is free.
31
Insider Decl.
n/a
Thresholds
€48,540
24 ops.
Buy Volume
€34,236
1 ops.
Sell Volume
43Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 January 2026
Declarations31 total
200,000 shares0Common StockSEC:0001213900-26-002457:0
2,000 shares@ US$0.190.7% of flowCommon StockSEC:0001213900-25-086835:0
Canonical exit: 9 Dec 2025 (T+90)
2,500 shares@ US$0.190.8% of flowCommon StockSEC:0001213900-25-085745:0
Canonical exit: 7 Dec 2025 (T+90)
2,500 shares@ US$0.200.9% of flowCommon StockSEC:0001213900-25-085209:0
Canonical exit: 4 Dec 2025 (T+90)
8,000 shares@ US$0.111.6% of flowCommon StockSEC:0001213900-25-061353:0
Canonical exit: 30 Sept 2025 (T+90)
1,000 shares@ US$0.110.2% of flowCommon StockSEC:0001213900-25-042044:0
Canonical exit: 7 Aug 2025 (T+90)
1,000 shares@ US$0.110.2% of flowCommon StockSEC:0001213900-25-009536:0
Canonical exit: 30 Apr 2025 (T+90)
4,500 shares@ US$0.111.0% of flowCommon StockSEC:0001213900-25-005972:0
Canonical exit: 22 Apr 2025 (T+90)
8,500 shares@ US$0.111.9% of flowCommon StockSEC:0001213900-25-000782:0
Canonical exit: 2 Apr 2025 (T+90)
2,500 shares@ US$0.160.8% of flowCommon StockSEC:0001213900-24-098947:0
Canonical exit: 10 Feb 2025 (T+90)
1,500 shares@ US$0.110.3% of flowCommon StockSEC:0001213900-24-076972:0
Canonical exit: 5 Dec 2024 (T+90)
3,000 shares@ US$0.090.5% of flowCommon StockSEC:0001213900-24-073380:0
Canonical exit: 25 Nov 2024 (T+90)
300,000 shares0Common StockSEC:0001213900-24-070325:0
300,000 shares0Common StockSEC:0001213900-24-070312:0
2,500 shares@ US$0.070.3% of flowCommon StockSEC:0001213900-24-064901:0
Canonical exit: 30 Oct 2024 (T+90)
3,000 shares@ US$0.070.4% of flowCommon StockSEC:0001213900-24-063318:0
Canonical exit: 20 Oct 2024 (T+90)
3,000 shares@ US$0.070.4% of flowCommon StockSEC:0001213900-24-061352:0
Canonical exit: 13 Oct 2024 (T+90)
4,000 shares@ US$0.131.0% of flowCommon StockSEC:0001213900-24-053578:0
Canonical exit: 15 Sept 2024 (T+90)
750 shares@ US$0.140.2% of flowCommon StockSEC:0001213900-24-045449:0
Canonical exit: 18 Aug 2024 (T+90)
3,000 shares@ US$0.150.9% of flowCommon StockSEC:0001213900-24-043955:0
Canonical exit: 13 Aug 2024 (T+90)
3,000 shares@ US$0.110.7% of flowCommon StockSEC:0001213900-24-040660:0
Canonical exit: 5 Aug 2024 (T+90)
5,000 shares@ US$0.111.1% of flowCommon StockSEC:0001213900-24-035642:0
Canonical exit: 23 Jul 2024 (T+90)
5,000 shares@ US$0.151.5% of flowCommon StockSEC:0001213900-24-023828:0
Canonical exit: 16 Jun 2024 (T+90)
7,000 shares@ US$0.091.2% of flowCommon StockSEC:0001213900-24-014555:0
Canonical exit: 3 Mar 2024 (T+90)
3,000 shares@ US$0.19991.2% of flowCommon StockSEC:0001013762-23-005064:0
Canonical exit: 14 Jan 2024 (T+90)
25 of 31 declarations
关于 Bespoke Extracts, Inc.
Bespoke Extracts, Inc. 是一家在美国上市的微型股公司，在 OTCQB 上以股票代码 BSPK 交易；根据审查的 SEC 文件，它目前未在纽约证券交易所或纳斯达克上市。该公司在内华达州注册成立，总部位于美国科罗拉多州奥罗拉。其业务概况随时间发生了重大变化：虽然 Bespoke 最初涉足 CBD 相关产品，但其目前的战略重点是美国受监管的大麻市场，更侧重于大麻衍生消费品和生产服务。 该公司可追溯到 1988 年，但现代大麻业务实际上是在 2023 年收购了科罗拉多州奥罗拉一家获得州许可的成人用大麻浸泡产品运营后启动的。通过其全资子公司 Bespoke Extracts Colorado, LLC，该集团运营着一家大麻浸泡产品制造工厂。自收购以来，Bespoke 已扩展到预卷生产和相关合同制造，围绕着专注于大麻消费品牌和许可供应关系的组合进行定位。 主要产品和品牌包括预卷大麻香烟（或称预卷），以及 Fresh Joints、Doobskis、DutchBlunts 和 Wee Joints 等品牌消费品。该公司声明其拥有、制造并分销这些产品给科罗拉多州获得许可的大麻药房。这种运营模式表明了一种混合战略：部分是品牌消费品，部分是为零售合作伙伴提供制造和生产服务。对于这种规模的公司来说，这种组合可能很有吸引力，因为它将直接品牌建设与来自药房客户的经常性生产量结合起来。 从竞争角度来看，Bespoke Extracts 在高度分散和竞争激烈的大麻行业中仍然是一个小型运营商。其竞争优势可能来自于产品质量、法规遵从性、生产可靠性以及与获得许可的药房保持关系的能力。它不是一家全国性的多州运营商；相反，它似乎是一家专注于科罗拉多州的专业公司，地理足迹较窄，但运营灵活性可能更大。这也意味着该公司面临行业特有的逆风，例如价格压力、合规成本和融资限制，这些因素继续影响美国的大麻企业。 从地理上看，该业务集中在科罗拉多州，生产和分销均在此地。最近 2025 年的公司披露强调了“The Joint Company”的战略品牌重塑，以及 2025 年第一季度适度的收入增长、毛利润改善和运营费用降低。总而言之，这些更新表明管理层专注于效率、品牌建设和执行，而不是快速的地域扩张。对于讲法语的投资者来说，Bespoke Extracts 最好被视为健康与制药领域高度投机的美国大麻微型股，其运营基础狭窄，专注于本地市场，并拥有不断发展但明确定义的产品和分销战略。
